Literature DB >> 26355962

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK.

Neil Goodman, Andre Guay, Paresh Dandona, Sandeep Dhindsa, Charles Faiman, Glenn R Cunningham.   

Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26355962     DOI: 10.4158/EP14434.PS

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  19 in total

1.  Are low levels of 25(OH) vitamin D and testosterone clinically relevant in men with paraplegia?

Authors:  John E Morley
Journal:  J Spinal Cord Med       Date:  2016-04-13       Impact factor: 1.985

Review 2.  Opioid-Induced Androgen Deficiency (OPIAD): Diagnosis, Management, and Literature Review.

Authors:  Timothy K O'Rourke; Matthew S Wosnitzer
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

Review 3.  Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.

Authors:  Kathryn E Berkseth; Arthi Thirumalai; John K Amory
Journal:  Med Clin North Am       Date:  2016-07       Impact factor: 5.456

Review 4.  Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?

Authors:  Dimitri C Cassimatis; Matthew T Crim; Nanette K Wenger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-12

5.  Trends in testosterone prescription amongst medical specialties: a 5-year CMS data analysis.

Authors:  Isabelle V Carter; Michael J Callegari; Tarun K Jella; Amr Mahran; Thomas B Cwalina; Wade Muncey; Aram Loeb; Nannan Thirumavalavan
Journal:  Int J Impot Res       Date:  2022-01-07       Impact factor: 2.896

6.  Effects of Testosterone and Progressive Resistance Exercise on Vascular Function in Older Men.

Authors:  Kerry L Hildreth; Robert S Schwartz; Joseph Vande Griend; Wendy M Kohrt; Patrick J Blatchford; Kerrie L Moreau
Journal:  J Appl Physiol (1985)       Date:  2018-09-06

Review 7.  Hypogonadotropic Hypogonadism in Men With Diabesity.

Authors:  Sandeep Dhindsa; Husam Ghanim; Manav Batra; Paresh Dandona
Journal:  Diabetes Care       Date:  2018-07       Impact factor: 19.112

Review 8.  Testosterone deficiency in the aging male.

Authors:  J Abram McBride; Culley C Carson; Robert M Coward
Journal:  Ther Adv Urol       Date:  2016-02

9.  Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis.

Authors:  Si Hyun Kim; Jae Joon Park; Ki Hong Kim; Hee Jo Yang; Doo Sang Kim; Chang Ho Lee; Youn Soo Jeon; Sung Ryul Shim; Jae Heon Kim
Journal:  Int Urol Nephrol       Date:  2021-06-05       Impact factor: 2.370

Review 10.  Advances in stem cell research for the treatment of primary hypogonadism.

Authors:  Lu Li; Vassilios Papadopoulos
Journal:  Nat Rev Urol       Date:  2021-06-29       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.